Try this search over all volumes: arteries
Results 1-0 of 0
What people are saying - Write a review
We haven't found any reviews in the usual places.
Lipoprotein metabolism in uremia
The present study
6 other sections not shown
albumin apo CIII apolipoprotein apolipoprotein CIII atherosclerosis AUCs bovine LPL chronic hemodialysis chronic renal failure CIII CIII concentrations decrease dialysis patients disease dyslipoproteinemia fluorescence intensity folic acid glomerular filtration rate HDL cholesterol HDL cholesterol concentrations healthy controls hemodialysis patients heparin hepatic lipase high density lipoprotein HL activities hyperlipidemia hypertriglyceridemia increase in fluorescence iohexol Kidney Int lipid abnormalities lipolysis lipoprotein and apolipoprotein lipoprotein lipase lipoprotein lipase activity lipoprotein metabolism lipoprotein profile LMWH low density lipoprotein low molecular weight Lp(a LPL inhibitory activities Lund moderate renal failure molecular weight heparin pathogenetic phospholipids plasma HL plasma homocysteine concentrations plasma lipase activities plasma LPL activities plasma LPL inhibitory postheparin plasma pre-dialysis heparin injection present study protein PTHintact pyridoxine renal insufficiency risk factor Serum Apolipoprotein serum concentrations serum HDL cholesterol serum lipid serum lipoprotein(a serum triglyceride concentrations significantly tissue treatment was switched triglyceride-rich lipoproteins unfractionated heparin uremia uremic patients vitro VLDL VLDL particles